BioMarin Pharmaceuticals BMRN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $10.86B.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's market capitalization?
- BioMarin Pharmaceuticals (BMRN) reported market capitalization of $10.86B in Q1 2026.
- How has BioMarin Pharmaceuticals's market capitalization changed year-over-year?
- BioMarin Pharmaceuticals's market capitalization decreased by 19.4% year-over-year, from $13.49B to $10.86B.
- What is the long-term trend for BioMarin Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's market capitalization has grown at a -6.6% compound annual growth rate (CAGR), from $16.1B to $11.42B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.